Ironwood Pharmaceuticals, Inc. Logo Image

Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. Banner Image

Ironwood Pharmaceuticals, Inc. has reached its limit for report views.

Please check back to see if Ironwood Pharmaceuticals, Inc. has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2015 Annual Report and Form 10K

Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

About Ironwood Pharmaceuticals, Inc.

201-500 Employees
Based in Cambridge, Massachusetts

Ironwood Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Constella name in the European Union.

Ticker:
IRWD
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drugs - Generic (See More Drugs - Generic Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol